Competing mortality risks: predicted cardiovascular disease risk versus predicted risk of breast cancer mortality in patients receiving adjuvant chemotherapy in a single Irish cent...

por Prior, Lisa, Featherstone, Hannah, O’Reilly, David, Nugent, Killian, Lim, Marvin, McCaffrey, John, Higgins, Michaela J, Kelly, Catherine M.
Publicado 2021

A Phase II Trial of Cabozantinib in Hormone Receptor‐Positive Breast Cancer with Bone Metastases

por Xu, Jing, Higgins, Michaela J., Tolaney, Sara M., Come, Steven E., Smith, Matthew R., Fornier, Monica, Mahmood, Umar, Baselga, Jose, Yeap, Beow Y., Chabner, Bruce A., Isakoff, Steven J.
Publicado 2020

Virtual oncology clinics during the COVID-19 pandemic

por O’Reilly, David, Carroll, Hailey, Lucas, Mairi, Sui, Jane, Al Sendi, Maha, McMahon, David, Darwish, Waseem, McLaughlin, Ronan, Khan, Mohammed Raza, Sullivan, Hazel O, Chew, Sonya, Dennehy, Colum, Kelly, Catherine M., McCaffrey, John, Greally, Megan, Carney, Desmond, Higgins, Michaela J.
Publicado 2021

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

por Garay, Joseph P, Karakas, Bedri, Abukhdeir, Abde M, Cosgrove, David P, Gustin, John P, Higgins, Michaela J, Konishi, Hiroyuki, Konishi, Yuko, Lauring, Josh, Mohseni, Morassa, Wang, Grace M, Jelovac, Danijela, Weeraratna, Ashani, Sherman Baust, Cheryl A, Morin, Patrice J, Toubaji, Antoun, Meeker, Alan, De Marzo, Angelo M, Lewis, Gloria, Subhawong, Andrea, Argani, Pedram, Park, Ben H
Publicado 2012